Controversy Around FDA’s Approval of Biogen Alzheimer’s Drug, Aducanumab

Release Date:

I discuss the safety and efficacy of the newest Alzheimer's drug treatments, aducanumab (Aduhelm) and lecanemab (Leqembi).

Controversy Around FDA’s Approval of Biogen Alzheimer’s Drug, Aducanumab

Title
Controversy Around FDA’s Approval of Biogen Alzheimer’s Drug, Aducanumab
Copyright
Release Date

flashback